Neyssa Marina

Publication Details

  • An evaluation of the factors that affect the health-related quality of life of children following myelosuppressive chemotherapy.

    Baggott CR, Dodd M, Kennedy C, Marina N, Matthay KK, Cooper B, Miaskowski C. Support Care Cancer. 2011; 19 (3): 353-61

    The purposes of this study, in children who were assessed 1 week after the administration of myelosuppressive chemotherapy were: to compare the total and subscale scores on a generic measure of health-related quality of life (HRQOL) to normative data from healthy children and describe the relationships between demographic, clinical, and symptom characteristics of children with cancer and generic and disease-specific dimensions of HRQOL.

    PubMedID: 20157746

Stanford Medicine Resources:

Footer Links: